Last edition
News about " Affordable Surgical Innovations"
US FDA Approves Uplizna for Adults with Generalised Myasthenia Gravis
The US FDA has approved Uplizna for adults with generalised myasthenia gravis, marking a significant advancement as the first and only CD19-targeted B-cell therapy for both anti-AChR and anti-MuSK antibody–positive patients, offering durable disease control with just twice-yearly dosing.
Affordable Surgical Innovations | 12/12/2025 | By Akanki
L'Oreal to Double Its Equity Stake in Galderma as Strategic Partnership Deepens
Galderma Group AG, the pure-play leader in the dermatology category, announced that L’Oréal Groupe plans to increase its equity investment in the company by acquiring an additional 10 percent stake from Sunshine SwissCo GmbH, a consortium led by EQT, the Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd. as the sellers.
Affordable Surgical Innovations | 09/12/2025 | By Darshana
Healthium Medtech and C-CAMP Launch Programme to Drive Affordable Surgical Innovations
Healthium Medtech, in collaboration with the Centre for Cellular and Molecular Platforms (C-CAMP), has launched the first cohort of the C-CAMP Healthium Innovations Programme for Surgical Interventions and Medical Technologies in Bengaluru.
Affordable Surgical Innovations | 26/08/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy